- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02972736
RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study (RODEO)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use fluoroscopically guided interventional procedures is progressively increasing over the past 20 years.Some previous reports have shown that the radiation dose absorbed by interventional cardiologists is the greatest registered by any medical staff exposed to X-rays. However in recent years new procedures have been introduced and validated in the setting of interventional cardiology and radiology and there is wide variation in patient dose among different procedures.
Radiation issue is an important issue for patients and operators due to the acute deterministic effects and most important for the long term stochastic risk of cancer induction: however this problem is often under-evaluated. Even if the stochastic risk is an all-or-none phenomenon for any individual cell, the greater the radiation exposure, the more cells are injured. Moreover non cancerous effects are possible such as cataract formation in the eye and the probability increases with increasing dose.
Radiation dose can be expressed in different ways: the Air Kerma is the amount of energy absorbed in a given mass of air, whereas the Dose Area Product (DAP) is the absorbed dose of radiation across a given surface area. Generally DAP measurements are more accurate than using Air Kerma measurements for the estimation of patient radiation dose as DAP allows for variations in field size. DAP consents a good estimation of the dose to the irradiated tissue and is an indicator for patient cancer risk.
Aim of our study is to evaluate the radiation dose exposure during different fluoroscopically guided interventional procedures comparing different specialties (electrophysiology, interventional radiology, interventional cardiology).
Methods From January 2013 to December 2015 all diagnostic or interventional procedures performed by interventional operators will be included in this multicenter study without exclusion criteria.
Collection of data will be retrospective in a dedicated database. Radiation exposure will be assessed measuring the DAP and fluoroscopy times for each procedure. Moreover for each procedure all the centers are requested to give information about operator, patient and procedure details.
End point of the study The primary end-point of the study is the comparison of DAP dose among interventional cardiologist, electrophysiologist and interventional radiologist procedures.
Secondary end-point of the study is to compare fluoroscopy times among different procedures.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All procedures for which DAP values are available
Exclusion Criteria:
- Procedures without DAP
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Interventional Cardiology
All procedures performed by interventional cardiologists
|
|
|
Electrophysiology
All procedures performed by electrophysiologists
|
|
|
Interventional Radiology
All vascular and non vascular procedures performed by interventional radiologists
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Radiation dose expressed as DAP
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alessandro Sciahbasi, MD, PhD, Ospedale Sandro Pertini - ASL RM2- Rome- Italy
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pertini04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Injuries
-
Institute of Oncology LjubljanaCompletedRadiation Necrosis | Radiation Injury | Radiation-Induced ComplicationsSlovenia
-
Liverpool Heart and Chest Hospital NHS Foundation...Rampart Health, L.L.C.RecruitingRadiation Injuries | Radiation Exposure | Radiation Exposure to Operator | Radiation SafetyUnited Kingdom
-
Affiliated Hospital to Academy of Military Medical...UnknownRadiation Injuries, ExperimentalChina
-
Instituto de Cardiologia do Rio Grande do SulCompletedRadiation Injury | Exposure to Ionizing Radiation | Occupational Exposure to RadiationBrazil
-
Royal Marsden NHS Foundation TrustUniversity College London Hospitals; Great Ormond Street Hospital for Children...Recruiting
-
SG Devices LLCNational Institutes of Health (NIH); University of MinnesotaNot yet recruiting
-
National Taiwan University HospitalWithdrawn
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingChronic Radiation Injury
-
Rambam Health Care CampusCompletedRadiation InjuriesIsrael
-
Menssana Research, Inc.Memorial Sloan Kettering Cancer Center; Emory University; Department of Health... and other collaboratorsUnknownRadiation InjuryUnited States
Clinical Trials on Radiation dose expressed as DAP
-
HK inno.N CorporationUnknown
-
University of ChicagoActive, not recruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Hai-Qiang Mai,MD,PhDRecruitingNasopharyngeal Cancinoma (NPC)China
-
University of CincinnatiActive, not recruitingMetastatic Bone TumorUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedPneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) PneumoniaUnited States
-
Serum Institute of India Pvt. Ltd.Bill and Melinda Gates FoundationNot yet recruitingHuman Papillomavirus InfectionKenya, Mozambique, South Africa
-
Corewell Health EastActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Ohio State UniversityVarian Medical SystemsActive, not recruitingPneumonia | Covid-19 | Sars-CoV2United States, Colombia
-
Ospedale Sandro Pertini, RomaCompleted